---
title: "STAT+: Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial"
description: "The drugmaker Alkermes said a therapy called an orexin agonist for the first time showed potential to treat people with ADHD in an early-stage study."
author: "Elaine Chen"
section: health
published: 2026-10-06T13:32:44.776742+00:00
canonical: https://valorandventures.media/article/2ce970d6-c6ff-483d-884d-5e89398a03ff
publisher: "Valor & Ventures Media"
source: "STAT News"
source_url: https://www.statnews.com/2026/09/21/alkermes-orexin-agonist-adhd-study/?utm_campaign=rss
access: free
---

# STAT+: Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial

*The drugmaker Alkermes said a therapy called an orexin agonist for the first time showed potential to treat people with ADHD in an early-stage study.*

## Article

---
Elaine Chen · STAT News · Photo: Alkermes

---

Originally published by STAT News: https://www.statnews.com/2026/09/21/alkermes-orexin-agonist-adhd-study/?utm_campaign=rss